RTKN2 and hepatocellular carcinoma: For example, circ_103809 targets miR-620 to suppress proliferation and invasion in HCC [11], and hsa_circ_104348 modulates the miR-187-3p/RTKN2 axis in hepatocellular carcinoma progression [12].